MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Biochemical features of lipids spectrum in blood in patients with Parkinson’s disease

Z.A. Akbarkhodjaeva, F. Saidvaliev (Tashkent, Uzbekistan)

Meeting: 2016 International Congress

Abstract Number: 1814

Keywords: Lipid metabolism, Parkinsonism

Session Information

Date: Thursday, June 23, 2016

Session Title: Other

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To study characteristic of lipid levels in patients with PD.

Background: Currently, there is no clear data about the features of lipid metabolism in patients with Parkinson’s disease (PD). Results of several studies shows that hyperlipidemia is an adverse factor in the development of this disease. At the same time, according to other authors, high level of total cholesterol(TC) increases the risk of BP in the age group under the 55.

Methods: We examined 65 patients with PD, at the age from 38 to 74, with the diseases duration of 23 ±2 month. Degree of severity of disease according to the Hoehn and Yahr scale was 1-2. As a control for comparison was examined a group of 38 patients with other movement disorders – focal dystonia, at the ages 25-66 years. The second control group consisted of 35 patients in the ages of 29-71 years, without movement disorders (tension headache -18, motor neuron disease-9, traumatic brain and spine injury-8). All patients were not tooking statins and underwent biochemical analyzes of lipids spectrum in blood -TC, triglycerides (TG), high density lipoproteins (HDL), low density lipoproteins (LDL),very low density lipoproteins(VLDL).

Results: In the group of patients with PD, results of analyzes showed: TC – 5.65±0.49 mmol/L, TG-1.62±0.3 mg/dL, HDL-1.78 ±0.7 mmol/L, LDL–4.0±0.8 mmol/L, VLDL – 0.69 ± 0.5 mmol/L. In the group of patients with FD level of TC- 5.26±0.28 mg/dL, TG-1.41±0.17 mmol /L, HDL – 1.33±0.07 mmol/L, LDL-3.9±0.6 mmol/L, VLDL – 0.64 ±0.14 mmol / L. Lipid spectrum in blood of third group patients (without movement disorders) was following: TC-5.89±0.5 mg/dL, TG-1.70±0.1 mmol/L, HDL – 1,60±0,4 mmol/L, LDL- 4,03±0,8 mmol/L,VLDL-0,80±0,7 mmol/L.

Conclusions: Results of our research shows that the mean values of TC and LDL were higher than target levels in patients with FD and in patients without MD. At the same time in the majority of patients with PD (41 patients – 63%) level of TC in the blood was within the normal ranges from 3.5 to 5.5 mmol/L and only in 13 patients (20%) exceed 6,5 mmol/L. In the same group in the half of cases-in 32 patients (49%) – low values of TG (less than 1.5 mmol/L) were marked. The ambiguity of the data we received indicates the need to further study of characteristics of lipid metabolism in patients with PD.

To cite this abstract in AMA style:

Z.A. Akbarkhodjaeva, F. Saidvaliev. Biochemical features of lipids spectrum in blood in patients with Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/biochemical-features-of-lipids-spectrum-in-blood-in-patients-with-parkinsons-disease/. Accessed May 15, 2025.
  • Tweet
  • Email
  • Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/biochemical-features-of-lipids-spectrum-in-blood-in-patients-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley